Showing results (61-70 of 84) with videos related to
Sort By:
Pageof 9
Transplantation and Cellular Therapy|February 16, 2025
Autologous or Allogeneic Hematopoietic Stem Cell Transplantation as Front-Line Treatment for Adult Secondary Acute Myeloid Leukemia Patients: The PETHEMA Registry ExperienceJosefina Serrano, David Martínez-Cuadrón, Cristina Gil, et al.Transplantation and Cellular Therapy|April 10, 2021
Long-Term Outcomes After Autologous Versus Allogeneic Stem Cell Transplantation in Molecularly-Stratified Patients With Intermediate Cytogenetic Risk Acute Myeloid Leukemia: A PETHEMA StudyEduardo Rodríguez-Arbolí, David Martínez-Cuadrón, Rebeca Rodríguez-Veiga, et al.Bone Marrow Transplantation|May 7, 2026
Impact of molecular profiling in patients with acute myeloid leukemia undergoing allogeneic transplantation in first remission: a study by the PETHEMA groupRafael Colmenares, Eva Barragán, Rebeca Rodríguez-Veiga, et al.Cancers|June 10, 2022
Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory <i>FLT3</i>-ITD Mutation-Positive Acute Myeloid LeukemiaDavid Martínez-Cuadrón, Josefina Serrano, José Mariz, et al.Cancer|January 3, 2025
Treatment patterns and outcomes in secondary acute myeloid leukemia arising after hypomethylating agents: PETHEMA registry studyPilar Lloret-Madrid, Blanca Boluda, Joaquín Martínez-López, et al.Cancers|March 13, 2025
Conventional PCR Versus Next Generation Sequencing for Diagnosis of FLT3, IDH and NPM1 Mutations in Acute Myeloid Leukemia: Results of the PETHEMA PCR-LMA StudyBlanca Boluda, Rebeca Rodriguez-Veiga, Claudia Sargas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2025
Quizartinib for Newly Diagnosed <i>FLT3</i>-Internal Tandem Duplication-Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI StudyPau Montesinos, Rebeca Rodríguez-Veiga, Juan Miguel Bergua, et al.Leukemia|September 1, 2025
Long-term benefits of autologous stem cell transplantation versus intensive chemotherapy consolidation for acute myeloid leukemia patients: A propensity score matching analysis from the PETHEMA AML registryAna Alfonso-Pierola, David Martinez-Cuadrón, Rebeca Rodríguez-Veiga, et al.Haematologica|May 14, 2026
Impact of hematopoietic cell transplantation and quizartinib in patients with newly diagnosed FLT3-internal tandem duplication-negative acute myeloid leukemia: results from the QUIWI studyPilar Lloret-Madrid, Rebeca Rodríguez-Veiga, Juan Miguel Bergua, et al.American Journal of Hematology|April 22, 2026
Real-World Outcomes of FLAG-Ida Regimen in 1079 Adult Patients With First Relapsed/Refractory AML: A PETHEMA StudyGaspar Aspas Requena, Rebeca Rodríguez-Veiga, Cristina Gil, et al.Pageof 9